Oligometastatic Disease: When Stage IV Breast Cancer Could Be “Cured”
Although metastatic breast cancer remains an incurable disease, there are patients with a limited number of metastatic lesions that, in addition to systemic therapy, can be treated with “radical therapy” and sometimes reach the status of no long-term evidence of disease. Whether or not these patient...
Main Authors: | Maria Gion, Cristina Saavedra, Jose Perez-Garcia, Javier Cortes |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-10-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/21/5229 |
Similar Items
-
SABR in oligometastatic breast cancer: Current status and future directions
by: Rachel Stewart, et al.
Published: (2021-12-01) -
Stereotactic Body Radiotherapy for Patients with Lung Oligometastatic Disease: A Five-Year Systematic Review
by: Guillaume Virbel, et al.
Published: (2021-07-01) -
Outcome of lung oligometastatic patients treated with stereotactic body irradiation
by: Guillaume Virbel, et al.
Published: (2022-07-01) -
Proton Radiotherapy for Patients With Oligometastatic Breast Cancer Involving the Sternum
by: Andrew Johnson, BS, et al.
Published: (2021-11-01) -
Volumetric burden of metastatic lesions drives outcomes in patients with extracranial oligometastatic disease
by: Yilin Cao, et al.
Published: (2021-11-01)